LWLG shares surged approximately 42% in early trading on March 12, 2026, building on a 15% rally from the prior session, as the stock's multi-day momentum accelerated into the regular open. The primary catalyst is Lightwave Logic's newly announced silicon photonics development agreement with Tower Semiconductor (TSEM), integrating its electro-optic polymer modulator technology into Tower's PH18 platform.

GIII shares fell approximately 15.65% in early trading on March 12, 2026, after the company reported its fiscal Q4 and full-year 2026 earnings before the bell. Q4 net sales dropped 8.1% year-over-year to $771.5 million, missing Wall Street's consensus estimate of approximately $792 million.

HIMX shares surged approximately +33% in premarket trading on March 12, 2026, with the stock climbing from a prior close of $9.15 to around $12.19–$12.56. The primary catalyst is a renewed wave of AI-driven semiconductor enthusiasm surrounding Himax's Co-Packaged Optics (CPO) technology and its potential role as a supplier to major players including NVIDIA and Taiwan Semiconductor Manufacturing.

TIC shares are down approximately 15% in premarket trading on March 12, 2026, ahead of the regular session open. Primary catalyst: TIC Solutions reported Q4 2025 earnings before market open, posting an adjusted loss of $0.25 per share — a miss of $0.33 against the analyst consensus of -$0.08 per share.

PATH shares fell approximately 10% in premarket trading on March 12, 2026, reversing the prior session's 6.82% gain, as investors digested Q4 fiscal 2026 earnings released after the close on March 11. The primary catalyst for the selloff was disappointing FY2027 revenue guidance, which implies approximately 8–9% top-line growth — a notable deceleration from the 13% growth delivered in FY2026.

NTSK shares are trading down approximately 20% in premarket trading on March 12, 2026, following the company's Q4 fiscal 2026 earnings release after the close on March 11. The primary catalyst is not the earnings themselves — which beat expectations — but an imminent and massive lock-up expiration scheduled for March 13, 2026, when approximately 390 million shares of Class A common stock become eligible for public sale.

Penny stocks in the oil sector are exploding in trading volume amid a massive oil price rally, with the USO ETF hitting a record $12.4 billion in daily trades—up 1,000% YTD and surpassing peaks from 2020, 2022, and 2025. Geopolitical tensions from the ongoing Iran war are driving oil above $100 per barrel, creating supply shocks and opportunities for high-volatility plays in exploration, drilling, and production.

Top hedge funds like Millennium, Citadel, and Bridgewater showed limited direct accumulation of penny stocks in Q4 2025 13F filings, but rotations into biotech, energy, and defense sectors highlight indirect interest in low-priced plays under $5. New entries and increased positions focused on volatile sectors like biotech (e.g., ABCL) and energy (e.g., AMPY), with full exits from overvalued names signaling a hunt for undervalued pennies amid market uncertainty.

RERE fell roughly 10% today, giving back a portion of its strong gains over the past year and month, as traders reacted to fresh earnings and guidance. The company delivered robust Q4 2025 results, with revenue growth near 30% year over year and earnings per share ahead of consensus estimates, underscoring continued operational momentum.

FICO fell over 9% today, extending a multi‑week downtrend that has already knocked the stock more than 7% lower since its last earnings update. The decline comes despite strong recent financial results, including double‑digit revenue growth, expanding margins, and repeated earnings beats.

HMY shares are trading down approximately 13% in early session trading on March 11, 2026, following the release of the company's H1 FY26 interim results. Revenue of R44.4 billion (~US$2.6 billion) missed analyst consensus estimates of R47.56 billion, a significant shortfall that spooked investors.

Shares of AngloGold Ashanti plc (AU) are down approximately 5.00% in early trading on March 11, 2026, falling from a prior close of $108.26 to around $102.85. The primary driver is a renewed pullback in gold prices, which has weighed heavily on gold mining equities across the board.

ORCL shares surged approximately +10.49% in Wednesday's premarket session, trading around $165.07 versus Tuesday's closing price of $149.40. The primary catalyst is Oracle's Q3 FY2026 earnings beat, with adjusted EPS of $1.79 vs. the $1.70 consensus estimate, and revenue of $17.2 billion topping the $16.92 billion forecast.

NBIS shares surged approximately +10% in premarket trading on March 11, 2026, from a prior close of $96.32. The primary catalyst is the imminent addition of Nebius Group to the Bloomberg 500 (B500) Index, effective prior to the open of trading on Thursday, March 12, 2026.

KOS shares are down approximately 20% in premarket trading on March 11, 2026, having shed roughly 20.31% across the last two sessions (Tuesday close and premarket Wednesday). The primary catalyst is Kosmos Energy's announcement of a massive $185.25 million public equity offering priced at $1.90 per share — a steep discount to recent trading levels.

AVAV shares dropped approximately 10% in premarket trading on March 11, 2026, following a disappointing Q3 fiscal 2026 earnings report released after the prior session's close. Q3 revenue of $408.0 million came in far below analyst consensus of approximately $475–$488 million, representing a massive top-line miss.

Over the past two weeks, PLTR has climbed from roughly the high‑130s to the mid‑150s, a gain of about 12–14%, with a series of strong up days between March 2 and March 6.

Average daily equity purchases by retail investors on S&P 500 down days in 2026 are at the highest level on record, running about 100% above the peak intensity seen during the 2021 meme‑stock boom.

Technology recently peaked near 35% of the S&P 500 and has slipped over the last year, while Energy plus Materials remain near historically low combined weight at roughly 6%, which suggests the gap is still unusually wide.

CNC shares fell approximately 10% during Tuesday's session, extending a prolonged selloff in the managed care sector. The primary catalyst is intensifying investor concern over federal Medicaid and ACA funding cuts tied to the "One Big Beautiful Bill Act" (OBBBA), which threatens to shrink the government-sponsored insurance pools that Centene depends on for the majority of its revenue.